Skip to content

Evaluation of EarlySense Home Care Tele-monitoring Device

Study Protocol for Evaluation of EarlySense Home Care Tele-monitoring Device - A Contact-Free System for Measuring Heart Rate, Respiratory Rate and Motion For Early Detection of Deterioration For Cardiac Patients at Home

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02318004
Enrollment
50
Registered
2014-12-17
Start date
2014-12-31
Completion date
2016-02-29
Last updated
2014-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Surgery, Myocardial Infarction

Keywords

telemonitoring

Brief summary

The aims of the present study are to evaluate the information obtained by the EarlySenese monitoring system and examine correlation of the obtained data and clinical events.

Detailed description

The EarlySense Home Care System developed by EarlySense, Ltd., is a contact-less tele-monitoring system. The system is intended for continuous monitoring of patients' respiration rate, heart rate and patient's motion. The system, which monitors the patient while in bed, consists of a piezoelectric sensor that produces an electrical signal in response to physiological stimulation, and a microprocessor control unit that analyzes the recorded signal and identifies respiratory and heart rates and patient motion, while patient is in bed,. In addition, the system indicates patient's in or out of bed status. The system also provides alerts if either of the physiological parameters cross predefined threshold settings (e.g., high/ low heart rate or respiratory rate, or motion or time in bed). The system saves patient's parameters and then flags the patients, as those to have changes in their vital signs and motion, or those that do not have noteworthy changes during recent hours of monitoring. Flagging of the patients are based on changes detected in patients' baseline vital signs (heart and respiratory rates and patterns) and well as recognition of changes in patients motion and in and out of bed status in comparison to set thresholds. The aim of this study is to evaluate relevance of the information (vital sign trends, alerts and flags) as provided by the EarlySense Home Care Tele-monitoring system to medical staff in Sheba Medical Center's Heart Rehabilitation Institute (Shelev) in order proactively monitor patients at home. The correlation between the EarlySense system alerts and flags to patient deterioration and hospital readmission will be studied.

Interventions

Non invasive nocturnal monitoring of heart and respiratory rate and subjects movement out of bed.

Sponsors

EarlySense Ltd.
CollaboratorINDUSTRY
Sheba Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients who resided in Shelev following a cardiac event (cardiac surgery, myocardial infarction, pacemaker implantation or other cardiac interventions ) 2. Age ≥ 21 years 3. Any patient hosted in Shelev with geographically resident within 50 Km from Sheba Medical Center 4. Patients agrees to sign the consent form and able to comply with study protocol. 5. Sleeps on a mattress

Exclusion criteria

1. Planned readmission within 30 days of discharge from hospital 2. Discharge to hospice care. 3. Patients with cognitive disabilities 4. Patient's major treating hospital is not the Sheba Medical Center

Design outcomes

Primary

MeasureTime frameDescription
Diagnositic Utility30 days following enrollmentPositive percent agreement between the EarlySense device and clinical events as adjudicated by health-care personal

Secondary

MeasureTime frameDescription
System Acceptance30 days following enrollmentAssess the acceptability of the EarlySense Home care device by clinicians and by patients and their families in their own home as determined by a provided questioner.

Countries

Israel

Contacts

Primary ContactRobert Klempfner, MD
klempfner@gmail.com
Backup ContactMeirav Moreno, Msc
Merav.Moreno@sheba.health.gov.il

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026